Literature DB >> 18264937

TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy.

Sachiko Nonaka Takahashi1, Takayuki Fujita, Teruyiki Takahashi, Yuki Wada, Yoshinobu Fuke, Atsushi Satomura, Koichi Matsumoto.   

Abstract

The degree of tubulointerstitial fibrosis is a poor prognostic indicator in IgA nephropathy (IgAN). Recently, connective tissue growth factor (CTGF) was observed to be strongly up-regulated in human proliferative and fibrogenic diseases. Renal biopsy specimens were obtained from the 20 patients with IgAN. Based on a previously reported study (MDRD study), all cases were categorized into 2 groups. Group A included patients with urinary protein (u-protein) <1.0 g/day, and group B, those with u-protein > or =1.0 g/day. Expressions of transforming growth factor beta1 (TGF-beta1) and CTGF mRNAs in tubular epithelial cells (TECs) were examined in all cases using rapid in situ hybridization (rISH). Significantly strong and diffuse expressions of TGF-beta1 and CTGF mRNAs were observed in proximal TECs in group B, while the expressions of these 2 mRNAs were weak in proximal TECs in group A and in glomerular resident cells in both groups. These results closely correlated with the degree of disorder in conventional pathohistological findings and clinical parameters except for u-protein level. The increase of u-protein level is one of the most important factors influencing the expression of TGF-beta1 and CTGF mRNAs in TECs. Therefore, the authors conclude that both u-protein level and expressions of these 2 mRNAs in TECs were significantly correlated with the degree of tubulointerstitial damage in IgAN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264937

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  7 in total

Review 1.  How tubular epithelial cells dictate the rate of renal fibrogenesis?

Authors:  Kevin Louis; Alexandre Hertig
Journal:  World J Nephrol       Date:  2015-07-06

2.  (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.

Authors:  Yayoi Saegusa; Chiharu Sadakane; Junichi Koseki; Yoshihiro Hasegawa; Shoichiro Shindo; Shuichi Takeda; Hiroshi Takeda; Tomohisa Hattori
Journal:  Clin Exp Nephrol       Date:  2010-09-04       Impact factor: 2.801

3.  Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.

Authors:  Maartje C J Slagman; Tri Q Nguyen; Femke Waanders; Liffert Vogt; Marc H Hemmelder; Gozewijn D Laverman; Roel Goldschmeding; Gerjan Navis
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

4.  CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.

Authors:  Elsa Sánchez-López; Sandra Rayego; Raquel Rodrigues-Díez; Javier Sánchez Rodriguez; Raúl Rodrigues-Díez; Juan Rodríguez-Vita; Gisselle Carvajal; Luiz Stark Aroeira; Rafael Selgas; Sergio A Mezzano; Alberto Ortiz; Jesús Egido; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

Review 5.  Dendritic cells and macrophages in kidney disease.

Authors:  Koichi Matsumoto; Noboru Fukuda; Masanori Abe; Takayuki Fujita
Journal:  Clin Exp Nephrol       Date:  2009-08-18       Impact factor: 2.801

6.  Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

Authors:  Roger M Mason
Journal:  Int J Exp Pathol       Date:  2012-10-30       Impact factor: 1.925

7.  [Correlation between TGF-B gene promoter-509C/T polymorphism and IgA nephropathy in core families in Guangxi Zhuang Autonomous Region and the therapeutic effect of dendrobium].

Authors:  Shiliang Li; Jie Wang; Peng Huang; Xianjun Gu; Meiying Huang; Feifan Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.